Amin F, König C, Zhang J, Kalinichenko LS, Königsmann S, Brunsberg V, Riemensperger TD, Müller CP, Gerber B. Compromising Tyrosine Hydroxylase Function Extends and Blunts the Temporal Profile of Reinforcement by Dopamine Neurons in . J Neurosci. 2025 45(11):e1498242024.
Bach P, Kiefer F. New Approaches to Addiction Treatment Based on Learning and Memory. Curr Top Behav Neurosci. 2025 72:689-717. Epub 2023 Dec 12.
Baumann G, Fischer R, Reinhard I, Hoffmann S, Kiefer F, Leménager T, Bach P. Investigating decision-making under risk in pathological gambling using a virtual slot machine - a pilot eye-tracking study. Eur Addict Res. 2025 31(5):308-324. Epub 2025 Aug 26.
Bekier N, Frischknecht U, Eidenmueller K, Grimm F, Bach P, Stenger M, Kiefer F, Hermann D. Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients. Eur Arch Psychiatry Clin Neurosci. 2025 275(2):565-572. Epub 2024 Mar 19.
Biondi-Zoccai G, Lauretti A, Agewall S, Andres E, Audisio RA, Bhatt DL, Citerio G, Drezner JA, Eggermont A, Erol C, Ersche KD, Ferriero G, Heusch G, Indolfi C, Insel PA, Lavie CJ, La Vecchia C, Maffulli N, Montecucco F, Moliterno DJ, Nattel S, O'Kane P, Oliaro E, Pelliccia A, Picard M, Pozzilli P, Quaglia F, Riha RL, Sarkar R, Scicchitano P, Teboul JL, Stahel HT, Wold LE, Booz GW, Artificial Intelligence in Medical Publishing (AIMPub) Working Group AIMPub. Perspectives on artificial intelligence in medical publishing: a survey of medical journal editors. J Cardiovasc Pharmacol. 2025 86(4):374-383. Epub 2025 Jul 22.
Chestnykh D, Kalinichenko LS, von Hörsten S, Kornhuber J, Müller CP. The mirror preference test: A reverse translational approach to study anomalous subjective experience in rats. Brain Res Bull. 2025 222:111247. Epub 2025 Feb 5.
Chestnykh D, Mühle C, Schumacher F, Kalinichenko LS, Löber S, Gmeiner P, Alzheimer C, von Hörsten S, Kleuser B, Uebe S, Ekici AB, Gulbins E, Kornhuber J, Jin HK, Bae JS, Lourdusamy A, Müller CP. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Mol Psychiatry. 2025 30(7):2891-2906. Epub 2025 Jan 17.
Eidenmueller K, Hoffmann S, Kammler-Sücker K, Wenger L, Mazza M, Mühle C, Stenger M, Meixner G, Kiefer F, Lenz B. Reactivity to Smoking Cues in a Social Context: Virtual Reality Experiment. JMIR Form Res. 2025 9:e71285.
Freus NK, Wank I, Häfele M, Kalinichenko LS, Müller CP, Strobelt S, Ludwig A, Hess A, Kreitz S. Pharmacological and resting state fMRI reveal Osteocalcin's effects on mouse brain regions with high Gpr37 and Gpr158 expression. Sci Rep. 2025 15(1):10116.
Gerhardt S, Kroth M, Seeger A, Schmitt R, Fritz H, Diring L, Shevchenko Y, Ersche KD, Feld G, Vollstädt-Klein S. Increasing the smoking cessation success rate by enhancing improvement of self-control through sleep-amplified memory consolidation: protocol of a randomized controlled, functional magnetic resonance study. BMC Psychol. 2025 13(1):157.
Gihl J, Zacharias N, Hoffmann S, Thürauf N, Schaller G, Winterer G, Koopmann A, Kiefer F, Kornhuber J, Mühle C, Lenz B. No Relevant Associations Between Markers of Smoking Behaviour and Plasma Progesterone Concentrations: Findings From a Sex-Stratified Cohort Study. Addict Biol. 2025 30(8):e70071.
Graczyk MM, Cardinal RN, Lim TV, Nigro S, Mak E, Ersche KD. Deconstructing delay discounting in human cocaine addiction using computational modelling and neuroimaging. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 10(8):856-864. Epub 2024 Dec 26.
Hiß IC, Hoffmann S, Reinhard I, Siegmann EM, Bach P, Kiefer F, Fischer R, Jäger K, Lenz B. Gender- and sex-sensitive psychopharmacotherapy of alcohol use disorder: a systematic review and meta-analysis protocol. BMJ Open. 2025 15(12):e112002.
John U, Rumpf HJ, Hoffmann S, Meyer C, Kiefer F. [Long-term courses of alcohol dependence]. Nervenarzt. 2025 96(1):31-36. Epub 2024 Aug 21.
Kalinichenko LS, Zoicas I, Bienia AM, Bühner C, Robinson J, Kütemeyer J, Labonte A, Raveendran T, Warth L, Smaga I, Filip M, Eulenburg V, Rhein C, Fejtova A, Gulbins E, Kornhuber J, Müller CP. Brain acid sphingomyelinase controls addiction-related behaviours in a sex-specific way. Neurobiol Dis. 2025 206:106800.
Koopmann A, Hoell A, Schick A, Meyer-Lindenberg A, Kiefer F, Banaschewski T, Reininghaus U, Herpertz SC, Neukel C, Link T, Kammerer-Ciernioch J, Rindle J, Krisam Y, Hoffmann S, Kaiser A, Ardern I, Christmann N, Scharmann L, Grimmer Y. Suchterkrankungen und Elternschaft – Belastungen und Versorgung. Sucht. 2025 71(5):307-318.
Lim TV, Cardinal RN, Ziauddeen H, Regenthal R, Sahakian BJ, Robbins TW, Ersche KD. Atomoxetine reduces decisional impulsivity in human cocaine addiction. Biol Psychiatry. 2025 97(6):627-636. Epub 2024 Oct 29.
Müller CP, Khodamoradi M. The GABA receptor agonist baclofen inhibits the reconsolidation of methamphetamine reward memory in adolescent and adult REM sleep-deprived rats. Prog Neuropsychopharmacol Biol Psychiatry. 2025 141:111472.
Müller CP, Lenz B, Kornhuber J, Ebner-Priemer UW, Schwarz E, Ersche K, Kiefer F, Spanagel R. Phase-sensitive individualized pharmacotherapy for alcohol use disorder. Neuropharmacology. 2025 283:110745. Epub 2025 Oct 26.
Pfisterer M, Zimmermann S, Zaiser J, Gerhardt S, Vollstädt-Klein S, Kiefer F, Bach P. Biomarkers in alcohol use disorder - the promise and pitfalls of neuroimaging drug cue reactivity. Biomarkers in neuropsychiatry. 2025 12:100119.
Reinhardt P, Zacharias N, Fislage M, Böhmer J, Hollunder B, Reppmann Z, Wiehe A, Rajwich R, Dominick N, Ritter K, Bajbouj M, Wienker T, Gallinat J, Thürauf N, Kornhuber J, Kiefer F, Wagner M, Tüscher O, Walter H, Winterer G. Machine Learning Classification of Smoking Behaviours-From Social Environment to the Prefrontal Cortex. Addict Biol. 2025 30(8):e70056.
Sommer WH, Canals S. Alcohol-Induced Changes in Brain Microstructure: Uncovering Novel Pathophysiological Mechanisms of AUD Using Translational DTI in Humans and Rodents. Curr Top Behav Neurosci. 2025 72:595-617.
Stüben N, Muscheidt R, Kiefer F, Soyka M. Web-based interventions for treatment-seeking individuals with hazardous alcohol consumption: analysis of clinical characteristics and motives for abstinence. Alcohol Alcohol. 2025 60(3)
Suhaimi FW, Khari NHM, Hassan Z, Müller CP. Exploring the cognitive effects of kratom: A review. Behav Brain Res. 2025 480:115387.
Trent S, Abdullah MH, Parwana K, Valdivieso MA, Hassan Z, Müller CP. Fear conditioning: Insights into learning, memory and extinction and its relevance to clinical disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2025 138:111310. Epub 2025 Mar 6.
Türkmen C, Machunze N, Lee AM, Bougelet E, Ludin NM, de Cates AN, Vollstädt-Klein S, Bach P, Kiefer F, Andreas JB, Kamphuis J, Schoevers RA, Emslie GJ, Hetrick SE, Viechtbauer W, van Dalfsen JH. Systematic Review and Meta-Analysis: The Association Between Newer Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2025 64(10):1148-1164. Epub 2025 Jan 17.
Varga L, Péntek B, Molnár B, Pérez-Cervera L, Selim MK, Díaz-Parra A, Moratal D, Sommer WH, Canals S, Mureșan RC, Moca VV, Ercsey-Ravasz M. Protocol to study brain dynamics of mammals through the hierarchy of complex correlation patterns defining a robust functional architecture. STAR Protoc. 2025 6(2):103693.
Vetter S, Schnabel S, Reichl M, Sirignano L, Grinevich V, Koopmann A, Spanagel R, Kiefer F, Sommer WH, Bach P. Intranasal oxytocin blunts amygdala response to negative affective stimuli in males and females with alcohol use disorder: a randomized controlled cross-over trial. Psychopharmacology (Berl). 2025 242(9):1995-2007. Epub 2025 Mar 31.
Vetter S, Weinberg J, Thomas BC, Kirchner M, Thalmann P, Klose C, Pfisterer M, Kölsch T, Oesterle S, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Link T, Bach P. Investigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial - ICONICplus Trial. BMJ Open. 2025 15(8):e106348.
Vollstädt-Klein S, Türkmen C, Grundinger N, Wieland A, Aggensteiner PM, Stock AK, Stein M, Moggi F, Bublatzky F, Kiefer F, Link T, Gerhardt S. Modification of inhibitory control and craving through transcranial direct current stimulation as an add-on treatment for substance use disorder: protocol for a randomized controlled study. BMC Psychol. 2025 13(1):1132.
Wenzel JG, Reichert M, Zech H, Wedemeyer F, Deeken F, Spitta G, Bach P, Lenz B, Ebner-Priemer UW, Kiefer F, Rapp MA, Walter H, Heinz A, Banaschewski T. One-year ecological momentary assessment of alcohol use, mood, and stress among individuals with alcohol use disorder during SARS-CoV-2 pandemics: a gender-specific reflection. Eur Arch Psychiatry Clin Neurosci. 2025 275(2):451-461. Epub 2024 Nov 19.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Bach P, Koopmann A. Glucose intake reduces alcohol craving and amplifies habituation to cue-induced brain activation in male patients with alcohol use disorder: A randomized, placebo-controlled crossover study examining male and female patients with AUD. Psychoneuroendocrinology. 2025 177:107456.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Koopmann A, Bach P. Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response. Eur Addict Res. 2025 31(4):251-263.
Wetzel L, Ohly O, Reichl M, Lenz B. Fetale Alkoholspektrumstörungen bei Erwachsenen. Psych up2date. 2025 19:389-405.
Wiegand A, Friske MM, Edelmann S, Bender A, Fischer L, Zill P, Koller G, Bakalkin G, Sommer WH, Hansson AC, Nieratschker V. Validation of and as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain. Int J Mol Sci. 2025 26(22)
Zaiser J, Hoffmann S, Zimmermann S, Gessner T, Deck M, Bekier N, Abel M, Radler P, Langejürgen J, Lenz B, Vollstädt-Klein S, Stallkamp J, Kirschbaum C, Kiefer F, Bach P. Individual stress reactivity predicts alcohol craving and alcohol consumption in alcohol use disorder in experimental and real-life settings. Transl Psychiatry. 2025 15(1):226.
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.